Skip to main content
Log in

Addressing the Challenge for Well Informed and Consistent Reimbursement Decisions

The Case for Reference Models

  • Editorial
  • Published:
PharmacoEconomics Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. National Institute for Health and Clinical Excellence (NICE). Guide to the methods of technology appraisal [online]. Available from URL: http://www.nice.org.uk/media/B52/A7/TAMethodsGuideUpdatedJune2008.pdf [Accessed 2011 Mar 2]

  2. Pharmaceutical Benefits Advisory Committee. Guidelines for preparing submissions to the PBAC [online]. Available from URL: http://www.health.gov.au/internet/main/publishing.nsf/content/pbacguidelines-index [Accessed 2011 Mar 2]

  3. Buxton MJ, Drummond MF, Van Hout BA, et al. Modelling in economic evaluation: an unavoidable fact of life. Health Econ 1997; 6: 217–27

    Article  PubMed  CAS  Google Scholar 

  4. Briggs A. Handling uncertainty in cost-effectiveness models. Pharmacoeconomics 2000; 17 (5): 479–500

    Article  PubMed  CAS  Google Scholar 

  5. Gray AM, Clarke PM, Wolstenholme JL, et al. Applied methods of cost effectiveness analysis in health care. New York: Oxford University Press, 2011

    Google Scholar 

  6. Kobelt G. Glaucoma care updates: health economics, economic evaluation, and glaucoma. J Glaucoma 2002; 11: 531–9

    Article  PubMed  Google Scholar 

  7. Sculpher M, Fenwick E, Claxton K. Assessing quality in decision analytic cost-effectiveness models: a suggested framework and example of application. Pharmacoeconomics 2000; 17 (5): 461–77

    Article  PubMed  CAS  Google Scholar 

  8. Scuffham PA. The assessment of pharmaceuticals for government subsidy in Australia: recent developments. J Med Econ 2007; 10: 163–9

    Article  Google Scholar 

  9. Philips Z, Ginnelly L, Sculpher M, et al. Review of guidelines for good practice in decision-analytic modelling in health technology assessment. Health Technol Assess 2004; 8 (36): iii-iv, ix-xi, 1–158

    PubMed  Google Scholar 

Download references

Acknowledgements

No sources of funding were used to prepare this manuscript. H.H. worked as an evaluator of submissions to PBAC between 2007 and 2009. J.K. has served as a member of the Economics Sub-Committee (ESC) of the PBAC since 2009.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Hossein Haji Ali Afzali.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ali Afzali, H.H., Karnon, J. Addressing the Challenge for Well Informed and Consistent Reimbursement Decisions. Pharmacoeconomics 29, 823–825 (2011). https://doi.org/10.2165/11593000-000000000-00000

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/11593000-000000000-00000

Navigation